Beauty Farm Medical and Health Industry Inc. (Beauty Farm) executed an on-market share repurchase on 4 June 2026, acquiring 24,000 ordinary shares at prices between HKD 17.64 and HKD 17.90 each. The transaction cost totaled HKD 0.43 million, equivalent to a volume-weighted average price of HKD 17.8054 per share.

Post-transaction, Beauty Farm’s outstanding share count (excluding treasury shares) declined by 0.0096% to 249.15 million shares, while treasury shares rose to 2.44 million. The company’s total issued share capital remains unchanged at 251.59 million shares, as the repurchased stock is being held in treasury.

The buyback falls under the repurchase mandate approved on 27 June 2025, which authorises the company to repurchase up to 23.58 million shares. Including the latest transaction, Beauty Farm has repurchased 2.44 million shares, representing 1.04% of the shares outstanding on the mandate date.

A 30-day moratorium on new share issuance or further sale/transfer of treasury shares is in effect until 4 July 2026, in line with Hong Kong Stock Exchange Main Board Rule 10.06(3)(a). The board confirms that the transaction complied with all applicable listing rules and regulatory requirements.